Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
42.55 USD
0.66%
Market Closed
Updated:
May 22, 2024
Bristol-Myers Squibb Co
Capital Expenditures
|
Bristol-Myers Squibb Co
Capital Expenditures Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Capital Expenditures
-$1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Capital Expenditures
-$4.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Pfizer Inc
NYSE:PFE
|
Capital Expenditures
-$3.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Capital Expenditures
-$3.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Capital Expenditures
-$649m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Capital Expenditures
-$7.6B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-21%
|
See Also
What is Bristol-Myers Squibb Co's Capital Expenditures?
Capital Expenditures
-1.2B
USD
-1.2B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Capital Expenditures amounts to -1.2B USD.
What is Bristol-Myers Squibb Co's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%
-8%
Over the last year, the Capital Expenditures growth was -6%. The average annual Capital Expenditures growth rates for Bristol-Myers Squibb Co have been -18% over the past three years , -6% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
